ESPR

Esperion Therapeutics, Inc. News Headlines

$32.13
*  
0.30
0.94%
Get ESPR Alerts
*Delayed - data as of Nov. 28, 2014 11:11 ET  -  Find a broker to begin trading ESPR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ESPR Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Merck IMPROVEs-IT Causing These Biotechs' Stock Prices to Improve Too
11/18/2014 4:00:58 PM - Motley Fool


Can The Uptrend Continue for Esperion (ESPR)? - Tale of the Tape
11/18/2014 9:38:41 AM - Zacks.com


AMGN Gets FDA Date, TTPH On Track, SAGE Keeps Calm, Busy Months Ahead For XNCR
11/10/2014 11:52:00 PM - RTT News


AMGN Gets FDA Date, TTPH On Track, SAGE Keeps Calm, Busy Months Ahead For XNCR
11/10/2014 11:52:00 PM - RTT News


Esperion Therapeutics Q3 14 Earnings Conference Call At 4:30 PM ET
11/10/2014 3:00:00 PM - RTT News


InsiderInsights.com Daily Round Up 10/21/14: AGCO, ESPR, FMI, BKCC
10/22/2014 10:56:00 AM - Seeking Alpha


Esperion Therapeutics Prices Public Offering Of 4.25 Mln Shares At $20 Per Share
10/16/2014 12:47:00 AM - RTT News


ESPR Prices Stock Offering At $20/Share
10/15/2014 8:52:00 PM - RTT News


Esperion Therapeutics Slumps: ESPR Falls 6.3% in Session - Tale of the Tape
10/13/2014 7:48:00 AM - Zacks.com


Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?
10/7/2014 7:30:16 AM - Motley Fool


Esperion Therapeutics (ESPR) in Focus: Stock Jumps 5.1% - Tale of the Tape
10/6/2014 8:18:09 AM - Zacks.com


Sector Update: Health Care Stocks Again Springing Leaks; Esperion Therapeutics Climbs to Record High on Positive Test Results for Anti-Cholesterol Drug
10/2/2014 12:22:03 PM - MT Newswires


Sector Update: Health Care
10/2/2014 12:17:31 PM - MT Newswires


ARDX Surges On Study Data, HBIO Opens Wallet, ZGNX On Watch, PTLA Creates Buzz
10/2/2014 3:05:00 AM - RTT News


Esperion Reports Favorable Cholesterol Drug Data
10/1/2014 5:55:00 PM - Dow Jones Business News


Esperion Reports Favorable Cholesterol Drug Data -- Update
10/1/2014 5:42:00 PM - Dow Jones Business News


Esperion Reveals Positive Top-line Phase 2b Results For ETC-1002 - Quick Facts
10/1/2014 4:48:00 PM - RTT News


Esperion To Present At BioCentury NewsMakers Conference; Webcast At 8:30 AM ET
9/26/2014 7:30:00 AM - RTT News


Esperion (ESPR) is in Overbought Territory: What's Next? - Tale of the Tape
9/25/2014 8:52:39 AM - Zacks.com


Esperion Therapeutics (ESPR) in Focus: Stock Up 13.4% - Tale of the Tape
9/25/2014 8:46:00 AM - Zacks.com


NASDAQ Biotechnology Top Performers (As Of Market Open September 11)
9/11/2014 7:27:38 AM - David Krein


MediWound (MDWD) Falls: Stock Goes Down 6.1% - Tale of the Tape
7/14/2014 7:47:13 AM - Zacks.com


Aerie Pharmaceuticals (AERI) in Focus: Stock Moves 6.8% Higher - Tale of the Tape
6/20/2014 8:18:00 AM - Zacks.com


Esperion Therapeutics (ESPR) in Focus: Stock Moves 5.6% Higher - Tale of the Tape
3/10/2014 8:21:01 AM - Zacks.com


Does Esperion Therapeutics Have A Blockbuster With ETC-1002?
9/9/2013 6:59:00 PM - Seeking Alpha